Treatment(s) now being considered-Surgery Posts on Medivizor
Navigation Menu

Treatment(s) now being considered-Surgery Posts on Medivizor

Bevacizumab therapy and surgery are associated with better outcomes in advanced colorectal cancer

Posted by on Jan 31, 2020 in Colorectal cancer | 0 comments

In a nutshell This study investigated whether bevacizumab (Avastin) therapy and surgery of the tumor can improve the outcomes of patients with advanced colorectal cancer (CRC). Researchers suggested that patients treated with bevacizumab have better outcomes when undergoing surgery. Some background CRC is one of the most common cancers...

Read More

Are abdominal infections a prognostic factor for recurrence after colorectal cancer surgery?

Posted by on Jan 26, 2020 in Colorectal cancer | 0 comments

In a nutshell This study investigated whether tummy infections (TIs) after surgery are associated with colorectal cancer outcomes. Researchers suggested that TIs might be associated with a shorter time until recurrence. Some background Colorectal cancer is a common cancer in the US affecting more than 145,000 people every year. Surgery is...

Read More

The effect of blood transfusion in the outcomes of colorectal cancer surgery

Posted by on Nov 17, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated the association between blood transfusions (BT) and inflammation after surgery on the outcomes of patients with colorectal cancer. Researchers suggested that blood transfusion was associated with poorer outcomes for these patients. Some background Colorectal cancer is the third most common cancer worldwide. The...

Read More

A comparison between conventional, laparoscopic and robotic rectal cancer surgery

Posted by on Nov 17, 2019 in Colorectal cancer | 0 comments

In a nutshell This study compared the effectiveness of open and non-invasive surgery (NIS) in the treatment of rectal cancer. Researchers suggested that open surgery is associated with improved complete tumor removal, while NIS is associated with fewer complications. Some background Colorectal cancer is one of the most common cancers in the US. The...

Read More

Tumor budding as a prognostic factor for treatment outcomes in patients with stage 2 colon cancer

Posted by on Aug 21, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated the role of tumor budding (TB) in predicting the best treatment for stage 2 colon cancer. Researchers suggested that TB could improve the effect of chemotherapy after surgery in these patients. Some background Stage 2 colorectal cancer accounts for one-third of patients who undergo curative surgery. Prognostic...

Read More

Is there a best duration of post-surgery chemotherapy in patients with colon cancer?

Posted by on Jul 28, 2019 in Colorectal cancer | 0 comments

In a nutshell This study compared a 3-month with a 6-month chemotherapy treatment after colon cancer surgery. Researchers suggested that the duration of the treatment should be chosen according to the patient condition. Some background Colorectal cancer is one of the most common cancers worldwide. Stage 2 and 3 colon cancer are common and curable...

Read More

Waiting at least 8 weeks for surgery after chemoradiotherapy increases rectal cancer response

Posted by on Jul 28, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated the best interval time between chemoradiation therapy and rectal cancer surgery for the best outcomes in patients with rectal cancer. Researchers suggested that waiting at least 8 weeks until the surgery increases the tumor response to the treatment. Some background The standard treatment for locally advanced...

Read More

Radiation therapy after surgery improves survival in patients with metastatic rectal cancer

Posted by on Jun 30, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated the survival outcomes in patients with rectal cancer after surgery with and without radiation therapy (RT). Researchers suggested that RT after surgery is associated with improved outcomes. Some background Rectal cancer is one of the most common cancers worldwide. Between 15 to 20% of patients present metastatic...

Read More

A comparison between two types of radiation therapy in the treatment of rectal cancer

Posted by on May 21, 2019 in Colorectal cancer | 0 comments

In a nutshell This study compared the effectiveness of two different types of radiation therapy to treat rectal cancer. Researchers suggested that high-dose endorectal brachytherapy (HDEB) is associated with improved tumor response. Some background The standard treatment for rectal cancer that has spread outside the rectum lining (T3 tumor) is...

Read More

Enhanced recovery pathways improve outcomes for patients with rectal cancer

Posted by on Apr 8, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated the outcomes of patients with rectal cancer who received enhanced recovery pathway (ERP) in combination with surgery. Researchers suggested that ERP was associated with longer overall survival. Some background The standard treatment for rectal cancer is surgery, chemotherapy and radiation therapy. However, rectal...

Read More

Consolidation chemotherapy before surgery improves the outcomes in advanced rectal cancer.

Posted by on Mar 29, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effectiveness and safety of consolidation chemotherapy after initial treatment in locally advanced rectal cancer. Researchers suggested that this treatment is safe and is associated with improved cancer outcomes.  Some background Colorectal cancer is the fifth most common cancer. From all the colorectal...

Read More